Skip to main content
Journal ArticleOPEN ACCESS

A Phase II multi institutional study of nivolumab in patients with advanced refractory biliary tract cancers (BTC)

  • Kim R
  • Kim D
  • Alese O
  • et al.
Annals of Oncology (2018) 29 v103
DOI: 10.1093/annonc/mdy149.008
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Poster presented at the ESMO World Congress on Gastrointestinal Cancer, 20-23 June 2018, Barcelona, Spain doi: 10.3252/pso.eu.20wcgic.2018

Cite

CITATION STYLE

APA

Kim, R., Kim, D., Alese, O., Li, D., El-Rayes, B., Shah, N., … Chung, V. (2018). A Phase II multi institutional study of nivolumab in patients with advanced refractory biliary tract cancers (BTC). Annals of Oncology, 29, v103. https://doi.org/10.1093/annonc/mdy149.008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free